Unimed Investments Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 1.58 Cr
- Company Age 37 Year, 28 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.50 Cr
- Revenue Growth 202.70%
- Profit Growth 27.27%
- Ebitda 212.82%
- Net Worth 15.22%
- Total Assets 37.31%
About Unimed Investments
Unimed Investments Limited (UIL) is a leading Public Limited Indian Non-Government Company incorporated in India on 27 January 1988 and has a history of 37 years. Its registered office is in Halol, Gujarat, India.
The Corporate was formerly known as Unimed Technologies Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.58 Cr.
The company currently has active open charges totaling ₹7.50 Cr.
Rajiv Pandya, Krishnaprasad Menon, and Vivek Mittal serve as directors at the Company.
Company Details
- Location
Halol, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U65999GJ1988PLC010304
- Company No.
010304
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Jan 1988
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Unimed Investments?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Pandya  | Additional Director | 15-Feb-2024 | Current |
| Krishnaprasad Menon | Director | 20-May-2019 | Current |
| Vivek Mittal | Director | 20-May-2019 | Current |
Financial Performance of Unimed Investments.
Unimed Investments Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 202.7% increase. The company also saw a substantial improvement in profitability, with a 27.27% increase in profit. The company's net worth Soared by an impressive increase of 15.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unimed Investments?
In 2023, Unimed Investments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sidmak Laboratories (India) Private LimitedRajiv Pandya, Krishnaprasad Menon and 1 more are mutual person
Airamatrix Private LimitedVivek Mittal is a mutual person
Aditya Infotech Private LimitedKrishnaprasad Menon is a mutual person
Mackinon Enterprises Private LimitedRajiv Pandya is a mutual person
Solar Power Technologies India LlpRajiv Pandya is a mutual person
- Rayo Enterprises Llp
Rajiv Pandya and Krishnaprasad Menon are mutual person
Charges (Loans)
₹7.50 Cr
₹0
Charges Breakdown by Lending Institutions
- Icici Bank Limited : 7.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 May 2000 | Icici Bank Limited | ₹7.50 Cr | Open |
How Many Employees Work at Unimed Investments?
Unlock and access historical data on people associated with Unimed Investments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unimed Investments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unimed Investments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
